31/05/2016 17:01:08 Cookie Policy +44 (0) 207 0700 961 Free Membership Login
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.50p -0.52% 1,445.00p 1,442.00p 1,443.00p 1,459.00p 1,440.00p 1,456.00p 10,117,137 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 23,923.0 10,526.0 174.3 8.3 70,328.04

Glaxosmithkline Share Discussion Threads

Showing 18826 to 18848 of 18850 messages
Chat Pages: 754  753  752  751  750  749  748  747  746  745  744  743  Older
DateSubjectAuthorDiscuss
31/5/2016
14:59
With any article I have learnt to look for the facts and ignore the subjective comments.
tim 3
31/5/2016
12:41
anhar I do see the logic in comparing different companies in different sectors. At the end of the day an investor wants the best return if all other things are equal. If you can understand many sectors and companies then looking at their growth/return profile to compare is very worthwhile - I do it all the time.
minerve
28/5/2016
14:19
"Motley Fool articles are generally poor and mostly not worth reading in my view." What it is and who it's by is clearly indicated in the url so why open it, especially if you don't understand its content.
gbh2
28/5/2016
11:58
The Tool used to be ok, but in the last year, it has gone down........use free articles to try and sell other services.
11_percent
28/5/2016
11:55
Motley Fool articles are generally poor and mostly not worth reading in my view. This is no exception because I see no logic in comparing Lloyds with GSK, being in such unrelated industries. The MF used to be radical, interesting, against the crowd with quality writers who had fresh ideas and new angles for people to look with good investment approaches that worked. But in recent years and with all their worthwhile writers gone, it has become what it used to preach against. Conventional, dull, crowd following, and poor quality writing.
anhar
28/5/2016
11:50
Graph here looking good..... 3 higher lows.
11_percent
28/5/2016
09:22
hTtp://www.fool.co.uk/investing/2016/05/27/lloyds-banking-group-plc-vs-glaxosmithkline-plc-which-is-the-better-growth-stock/
gbh2
28/5/2016
08:41
Regulators have given one of the world's largest drug companies approval to sell a new gene therapy. The treatment is for an illness called ADA-SCID which prevents babies from fighting off everyday infections. This is the first approval for a genetic therapy granted to a large multinational drug company, GSK. Commentators say the development marks the beginning of many more genetic medicines from so-called "Big Pharma". The condition is extremely rare and affects around two dozen babies each year. Approval of the gene therapy paves the way for the development of treatments for more widespread illnesses such as thalassemia and sickle cell disease. Hundreds of inherited disorders such as cystic fibrosis, muscular dystrophy and many types of blindness are caused by faulty genes.
tradermichael
25/5/2016
13:58
Totally agree EI.
garycook
25/5/2016
13:12
Had a look through some of the other sector companies last night following the recent Q updates, and what really strikes me is just how strong the GSK pipeline looks in comparison to many- at least on my very rudimentary take. LLY may look interesting if they really have made a significant breakthrough in alzheimers, one of their compounds in phase 111 atm.
essentialinvestor
25/5/2016
02:57
Up nice in the US overnight.
garycook
24/5/2016
15:31
Thanks - that's very good news: LONDON--GlaxoSmithKline PLC (GSK.LN) Tuesday said the Salford lung study for chronic obstructive pulmonary disease, in collaboration with Innoviva Inc. (INVA), has had positive headline results. The FTSE-100 healthcare company said the study showed that Relvar Ellipta achieved a superior reduction in exacerbations, compared with the usual care, in patients with COPD in an everyday clinical-practice setting. Study analyses are ongoing, the company said.
tradermichael
24/5/2016
11:07
hTtp://www.investegate.co.uk/Index.aspx?searchtype=3&words=gsk
gbh2
20/5/2016
11:57
Did anyone see the TV programme about the impact insects have had on human life, especially featuring the trade route established between China and the West? Oops, sorry, thought this was the silk thread.
solomon
20/5/2016
11:38
Hi bt, good to be busy, nice time of year before it gets too hot around my way late June to August time.
essentialinvestor
20/5/2016
11:37
Gbh..aye but even getting a tea break at the mo is a tad hard ..I'm self employed garden and grounds maintenance and it's the busiest time of my season
badtime
20/5/2016
11:20
Not 100% sure what reason ESSential.. Maybe the underlying mkt, have 2 many positions long !! i think we are not just up against the markets, but anyone on margin are up against there brokers, no matter what they say !!
amaretto1
20/5/2016
11:16
amaretto, if you are referring to antibiotic resistance infections, they killed an estimated 700,000 people worldwide last year, including 100,000 in Europe. A friend of mine nearly died of one, started with a simple mosquito bite which got infected after a few days, given a course of antibiotics which did not work, ended up being hospitalised and was lucky to survive, was told he was within a few hrs of death.
essentialinvestor
20/5/2016
10:55
Lost trust in this share. i think we are in for another bear attack planted story......we no the script !
amaretto1
20/5/2016
10:52
Isn't that what Mobile phones and tea breaks are to overcome ;)
gbh2
20/5/2016
10:28
Hi EI...so bust with work at the mo that I haven't got much time to watch
badtime
19/5/2016
16:25
May be wise bt, scaling in slowly. If the UKX takes a dive then GSK gets hit.
essentialinvestor
19/5/2016
16:19
Think I'll wait before adding
badtime
Chat Pages: 754  753  752  751  750  749  748  747  746  745  744  743  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20160531 16:01:08